Copyright
©2012 Baishideng Publishing Group Co.
World J Gastrointest Oncol. Dec 15, 2012; 4(12): 250-258
Published online Dec 15, 2012. doi: 10.4251/wjgo.v4.i12.250
Published online Dec 15, 2012. doi: 10.4251/wjgo.v4.i12.250
Table 1 Percentage of Fhit protein expression in hyperplastic aberrant crypt focus, dysplastic aberrant crypt focus and carcinoma n (%)
Fhit intensity | HACF | DACF | Carcinoma |
No staining | 0 | 0 | 12 (16) |
Weak | 18 (24) | 9 (37.5) | 18 (24) |
Moderate | 27 (36) | 9 (37.5) | 18 (24) |
Strong | 30 (40) | 6 (25) | 27 (36) |
Total cases | 75 (100) | 24 (100) | 75 (100) |
Table 2 Comparison of Fhit intensity between hyperplastic aberrant crypt focus, dysplastic aberrant crypt focus and carcinoma
Paired difference | mean | SD | t differentiation | P value |
HACF vs DACF | 0.25 | 0.46 | 1.528 | 0.17 |
HACF vs carcinoma | 0.0952 | 0.77 | 0.568 | 0.576 |
Table 3 Fhit in hyperplastic aberrant crypt focus, dysplastic aberrant crypt focus and carcinoma vs sex
Fhit intensity | Hyperplastic ACF (P = 0.521) | Dysplastic ACF (P = 0.915) | Carcinoma (P = 0.269) | ||||||
Male | Female | Total | Male | Female | Total | Male | Female | Total | |
Weak | 12 | 6 | 18 | 6 | 3 | 9 | 18 | 18 | |
Moderate | 24 | 3 | 27 | 6 | 3 | 9 | 15 | 3 | 18 |
Strong | 21 | 9 | 30 | 3 | 3 | 6 | 18 | 9 | 27 |
Total | 57 | 18 | 75 | 15 | 9 | 24 | 51 | 12 | 63 |
Table 4 Fhit in hyperplastic aberrant crypt focus, dysplastic aberrant crypt focus and carcinoma vs age
Fhit intensity | HACF (P = 0.265) | DACF (P = 0.655) | Carcinoma (P = 0.036) | ||||||
≤50 yr | > 50 yr | Total | ≤50 yr | > 50 yr | Total | ≤50 yr | > 50 yr | Total | |
Weak | 9 | 9 | 18 | 9 | 9 | 6 | 12 | 18 | |
Moderate | 6 | 21 | 27 | 6 | 3 | 9 | 9 | 9 | 18 |
Strong | 6 | 24 | 30 | 6 | 6 | 27 | 27 | ||
Total | 21 | 54 | 75 | 6 | 18 | 24 | 15 | 48 | 63 |
Table 5 Fhit in hyperplastic aberrant crypt focus, dysplastic aberrant crypt focus and carcinoma vs vegetarian and non-vegetarian
Fhit intensity | HACF (P = 0.035) | DACF (P = 0.076) | Carcinoma (P = 0.037) | ||||||
Veg | Non Veg | Total | Veg | Non Veg | Total | Veg | Non Veg | Total | |
Weak | 3 | 15 | 18 | 3 | 6 | 9 | 18 | 18 | |
Moderate | 27 | 27 | 9 | 9 | 18 | 18 | |||
Strong | 15 | 15 | 30 | 6 | 6 | 12 | 15 | 27 | |
Total | 18 | 57 | 75 | 9 | 15 | 24 | 12 | 51 | 63 |
Table 6 Fhit intensity in hyperplastic aberrant crypt focus, dysplastic aberrant crypt focus and carcinoma vs smoking
Fhit intensity | HACF (P = 0.007) | DACF (P = 0.641) | Carcinoma (P = 0.213) | ||||||
Non Smoker | Smoker | Total | Non Smoker | Smoker | Total | Non Smoker | Smoker | Total | |
Weak | 9 | 9 | 18 | 6 | 3 | 9 | 12 | 6 | 18 |
Moderate | 9 | 18 | 27 | 6 | 3 | 9 | 6 | 12 | 18 |
Strong | 30 | 30 | 6 | 6 | 21 | 6 | 27 | ||
Total | 48 | 27 | 75 | 18 | 6 | 24 | 39 | 24 | 63 |
Table 7 Fhit intensity in hyperplastic aberrant crypt focus, dysplastic aberrant crypt focus and carcinoma vs tumor differentiation
Tumor grade | Hyperplastic ACF (P = 0.719) | Dysplastic ACF (P = 0.232) | Carcinoma (P = 0.444) | ||||||||||
Fhit→ | + | ++ | +++ | Total | + | ++ | +++ | Total | -ive | + | ++ | +++ | Total |
Well diff | 3 | 3 | 3 | 3 | 7 | 3 | 10 | ||||||
Mod diff | 15 | 18 | 27 | 60 | 6 | 9 | 6 | 21 | 3 | 9 | 15 | 27 | 54 |
Poorly diff | 3 | 6 | 3 | 12 | 2 | 6 | 3 | 11 | |||||
Total | 18 | 27 | 30 | 75 | 9 | 9 | 6 | 24 | 12 | 18 | 18 | 27 | 75 |
Table 8 Fhit intensity in aberrant crypt focus vs tumor-node-metastasis stage
Fhit intensity | T (P = 0.325) | N (P = 0.938) | M (P = 0.396) | ||||||||
Tis | T1 | T2 | T3 | T4 | N0 | N1 | N2 | M0 | M1 | Total | |
Negative | 9 | 3 | 12 | 12 | 12 | ||||||
Weak | 3 | 14 | 1 | 10 | 8 | 18 | 18 | ||||
Moderate | 16 | 2 | 8 | 7 | 3 | 15 | 3 | 18 | |||
Strong | 24 | 3 | 27 | 0 | 27 | 27 | |||||
Total | 3 | 63 | 9 | 57 | 15 | 3 | 72 | 3 | 75 |
Table 9 Ki67 expression pattern and Fhit intensity inhyperplastic aberrant crypt focus, dysplastic aberrant crypt focus
Ki67 | HACF (P = 0.617) | DACF (P = 0.243) | ||||||
Fhit intensity→ | + | ++ | +++ | Total | + | ++ | +++ | Total |
Basal | 8 | 8 | ||||||
Expanded basal | 5 | 9 | 13 | 27 | ||||
Neck | 13 | 18 | 9 | 40 | 3 | 2 | 5 | 10 |
Surface | 6 | 7 | 1 | 14 | ||||
Total | 18 | 27 | 30 | 75 | 9 | 9 | 6 | 24 |
- Citation: Vaiphei K, Rangan A, Singh R. Aberrant crypt focus and fragile histidine triad protein in sporadic colorectal carcinoma. World J Gastrointest Oncol 2012; 4(12): 250-258
- URL: https://www.wjgnet.com/1948-5204/full/v4/i12/250.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v4.i12.250